insights_auto
Why is ACAD up 3.01%?
Dive Deeperchevron_right
ACAD:NASDAQ
ACADIA Pharmaceuticals Inc
$20.40
arrow_upward
+3.01%(+0.60) 1D
Oct 20, 3:10:57 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ACAD...
Open
$20.04
High
$20.49
Low
$19.86
Mkt. cap
3.51B
Avg. vol.
2.15M
Volume
947.56K
P/E ratio
9.22
52-wk high
$30.96
52-wk low
$18.39
EPS
$2.21
Beta
0.89
Shares outstanding
172.31M
No. of employees
797
Open
$20.04
High
$20.49
Low
$19.86
Mkt. cap
3.51B
Avg. vol.
2.15M
Volume
947.56K
P/E ratio
9.22
52-wk high
$30.96
52-wk low
$18.39
EPS
$2.21
Beta
0.89
Shares outstanding
172.31M
No. of employees
797
News stories
From web sources and news partners
ad-hoc-news.de
·
2 hours ago
Needham keeps USD 35.00 target for ACADIA Pharmaceuticals stock
https://www.dars.gov.et/
·
1 week ago
ACADIA Pharmaceuticals (ACAD) Edges Lower to $19.58 as Shares Trade Within a Defined Range - Liquidity Order Flow
Profile
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, California. Wikipedia
About ACADIA Pharmaceuticals Inc
CEOCatherine Owen Adams
Employees797
Founded1993
HeadquartersSan Diego, California, United States
SectorBiotechnology
Websiteacadia.com